Revenue Prospects by Product (Blood Glucose, Infectious Diseases, Rapid Coagulation, Rapid Cardiac Marker, Cholesterol, Pregnancy, Other) and Major National Markets with an Assessment of Leading Companies
POC Diagnostics – our new study reveals trends, R&D progress, and predicted revenues Where is the POC Diagnostics market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead Our 289-page report provides 161 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing POC Diagnostics market. See how to exploit the opportunities.
Forecasts to 2027 and other analyses reveal the commercial prospects • In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares. • You find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets Along with revenue prediction for the overall world market, there are forecasts for 7 POC Diagnostics Types, each forecasted at a global level.
POC Diagnostics, by Product Type • Blood Glucose • Infectious Diseases • Rapid Coagulation • Rapid Cardiac Marker • Cholesterol • Pregnancy • Other
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 15 leading national markets: • The US • Germany • The UK • Italy • Spain • France • Switzerland • Belgium • The Netherlands • Japan • China • India • Brazil • Russia • South Africa • RoW
The report also includes profiles and for some of the leading companies in the POC Diagnostics market, with a focus on this segment of these companies’ operations.
There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, China, India and Japan in particular, will continue to achieve high revenue growth to 2027.
Leading companies and the potential for market growth Overall world revenue for POC Diagnostics will surpass $5bn in 2027, our work calculates. We predict strong revenue growth through to 2027.
Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the POC Diagnostics Market report helps you In summary, our 289-page report provides you with the following knowledge: • Revenue forecasts to 2027 for the POC Diagnostics market with forecasts for 7 Types of POC testing – discover the industry’s prospects, finding the most lucrative places for investments and revenues • Revenue forecasts to 2027 for 15 key national markets – See forecasts for the POC Diagnostic market in the US, Japan, Germany, France, the UK, Italy, Spain, Belgium, The Netherlands, Switzerland, Brazil, China, India, South Africa and Russia • Discussion of what stimulates and restrains companies and the market • Prospects for established firms and those seeking to enter the market – including company profiles for 4 of the major companies involved in the POC Diagnostics market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else With our newly updated report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is for everybody needing commercial analyses for the POC Diagnostics market and leading companies. You will find data, trends and predictions.
Get our report today POC Diagnostic Systems Market Forecast 2017-2027: Analysis of POC Diagnostics Market Forecast 2017-2027: Revenue Prospects by Product (Blood Glucose, Infectious Diseases, Rapid Coagulation, Rapid Cardiac Marker, Cholesterol, Pregnancy, Other) and Major National Markets with an Assessment of Leading Companies.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Report Overview 1.1 Global POC Diagnostics Market Overview 1.2 Global POC Diagnostics Market Segmentation 1.3 Overview of Findings 1.4 Structure of the Report 1.5 Why You Should Read This Report 1.6 How This Report Delivers 1.7 Key Questions Answered by This Analytical Report 1.8 Who is This Report For? 1.9 Methodology 1.10 Frequently Asked Questions (FAQ) 1.11 Associated Visiongain Reports 1.12 About Visiongain
2. Introduction to In Vitro and POC Diagnostics 2.1 An Introduction to In Vitro Diagnostics 2.2 Classifying In Vitro Diagnostics 2.2.1 FDA Classifications 2.2.2 IVD Classifications in Australia 2.2.3 EDMA Classification 2.2.3.1 Clinical Chemistry 2.2.3.2 Immunochemistry 2.2.3.3 Haematology 2.2.3.4 Microbiology 2.2.3.5 Genetic Testing 2.2.3.6 Point Of Care Diagnostics: The Dominating Segment 2.3 Diagnostics Regulation of the IVD and POC Market 2.3.1 FDA and CLIA Regulation of IVD and POC Tests 2.3.2 Regulation of IVD/POC Diagnostics in the EU: The EC (European Commission) Classification 2.4 Regulation for In Vitro Diagnostics and POC Diagnostics 2.4.1 Top Ten Challenges in Regulation for In-Vitro Diagnostics 2.4.2 Device Excise Tax: A Threat to the Diagnostics Manufacturers 2.5 Uses of Point of Care (POC) Diagnostics 2.6 Advantages and Disadvantages of POC Diagnostics
3. The In Vitro Diagnostics Market, 2016 3.1 The Global In Vitro Diagnostics by Segment, 2016 3.2 The Global In Vitro Diagnostics Market Sales Forecast, 2016-2027 3.2.1 POC Diagnostics to Drive the Global IVD Market in the Next 10 Years 3.3 The Global Clinical Diagnostics Market Forecast, 2017-2027 3.4 The Global Point of Care Diagnostics Market: Sales Forecast 2017-2027 3.4.1 The Drive of Personalised Medicine
4. The Global Point of Care Diagnostics Market, 2016-2027 4.1 Market Overview, 2016 4.1.1 Self-testing Constituted the Largest Segment in the POC Market by the Point of Delivery 4.2 Point of Care Diagnostics Market Segmentation 4.3 POC Diagnostics Market, by Product 2017-2027 4.3.1 Market Overview, 2016 4.3.1.1 Scope of the Point of Care Diagnostics Market 4.3.1.2 Which Point of Care Diagnostic Segment Holds the Greatest Potential? 4.3.2 Market Forecast 2017-2027 4.3.3 Market Share of POC Diagnostics by Product 4.3.4 Blood Glucose Testing: Market Forecast, 2016-2027 4.3.5 Infectious Diseases Testing: Market Forecast, 2016-2027 4.3.6 Rapid Coagulation Testing: Market Forecast, 2016-2027 4.3.7 Rapid Cardiac Marker Testing: Market Forecast, 2016-2027 4.3.8 Cholesterol Testing: Market Forecast, 2016-2027 4.3.9 Pregnancy Testing: Market Forecast, 2016-2027 4.3.10 Other Testing: Market Forecast, 2016-2027 4.3.10.1 Cancer Diagnostics To Fuel Market Growth 4.3.10.2 The Haematology Market Will Be Driven by Blood Gas Tests 4.3.10.3 A Recently Discovered Biomarker for Sepsis Can Set The Potential For A Future Rapid Blood Test 4.3.10.4 Successful Clinical Study of Quo-Test A1c POCT Analyser For Diabetes Screening
5. Global POC Blood Glucose Testing Market, 2017-2027 5.1 Market Overview, 2016 5.2 Global POC Blood Glucose Testing Market, 2016 5.3 POC Blood Glucose Testing Market Forecast, 2016-2027 5.3.1 POC Blood Glucose Testing Market, By Type of Meter 5.3.2 POC Blood Glucose Testing Market, By Type of Meter 5.3.2.1 POC Blood Glucose Testing Devices Currently Available in the Market, 2016 5.3.3 Leading Regional Markets in the POC Blood Glucose Testing Market, 2016 5.3.4 Leading Companies in the POC Blood Glucose Testing Market, 2016 5.3.4.1 Other Companies in the POC Blood Glucose Testing Market: Recent Advances 5.3.5 Market Prospects to 2027: Which Product Will Lead the Market? 5.3.5.1 Advantages and Disadvantages of the Current CGM Tests in the Market 5.4 Drivers and Restraints for the POC Blood Glucose Testing Market, 2017-2027
6. Global POC Coagulation Testing Market, 2017-2027 6.1 Market Overview, 2016 6.2 Global POC Coagulation Testing Market in 2016 6.2.1 PT/INR Monitoring is the Largest Segment in the POC Coagulation Testing Market 6.3 Products Available in the POC Coagulation Testing Market, 2016 6.3.1 Patient Self-Testing is the Fastest Growing Segment 6.4 POC Coagulation Testing Market Segment by Components 6.4.1 Test Strips Generate 85.8% of the Sales in the PT/INR POC Testing Market 6.5 POC Coagulation Testing Market by Type of Drug 6.5.1 Anticoagulants 6.5.2 Heparins 6.5.3 Vitamin K Antagonists 6.5.4 Direct Thrombin Inhibitors 6.5.5 Direct Factor Xa Inhibitors 6.6 The POC Coagulation Testing Market by Regions, 2016 6.7 POC Coagulation Testing Market Forecast 2016-2027 6.8 Leading Companies in the POC Coagulation Testing Market, 2016 6.8.1 Roche Dominated the POC Coagulation Testing Market with CoaguChek XS System in 2016 6.8.2 Market Prospects to 2027: Who Will Be The Leading Product? 6.9 Drivers and Restraints for the POC Coagulation Testing Market, 2017-2027
7. Global Cardiac Marker Diagnostic Testing Market, 2017-2027 7.1 Market Overview, 2016 7.2 The Global Cardiac Marker Diagnostic Testing Market 2016 7.3 Cardiac Marker Diagnostic Testing Market Forecast 2017-2027 7.3.1 Leading Regional Markets in the Cardiac Marker Diagnostic Testing, 2016 7.3.2 Leading Companies in the Cardiac Marker Diagnostic Testing Market, 2016 7.3.3 Cardiac Marker Diagnostic Testing Market: Leading Products 7.3.4 Which Company is Dominating the Market? 7.3.5 A Leading Product: Abbott’s i-STAT 7.4 Drivers and Restraints for the Cardiac Marker Diagnostic Testing Market, 2017-2027 7.4.1 Challenges for the New Entrants in the Cardiac Markers Diagnostic Testing Market
8. Global POC Infectious Diseases Testing Market, 2017-2027 8.1 Market Overview, 2016 8.2 Global POC Infectious Diseases Testing Market, 2016 8.2.1 Breakdown of the POC Infectious Diseases Testing Market by Diseases, 2016 8.2.1.1 Influenza/Flu 8.2.1.2 HIV 8.2.1.3 Hepatitis 8.2.1.4 Tuberculosis 8.2.1.5 Sexually Transmitted Diseases 8.3 The POC Infectious Diseases Testing Market: Leading Products 2016 8.3.1 HIV Leading POC Diagnostics Products, 2016 8.3.1.1 HIV Diagnostics Kits Approved by the FDA, 2016 8.3.1.2 HIV POC Tests Pipeline, 2016 8.3.1.3 Driving Factors for Growth of HIV Rapid Testing: Past and Future 8.3.2 The Hepatitis POC Testing Market 8.3.2.1 First Rapid HCV Test Approved in the US 8.3.2.2 Driving Factors for Growth of Hepatitis Rapid Testing 8.3.3 The Influenza POC Testing Market and Leading Companies, 2016 8.4 POC Diagnostics Infectious Diseases Recent Trends 8.4.1 OraQuick Marker, OraSure Technologies: First OTC Home-Use Rapid HIV Test Approved by the FDA 8.4.2 Determine HIV-1/2 Ag/Ab Combo Test, Alere: First Rapid Diagnostic Test to Detect Both HIV-1 Antigen And HIV-1/2 Antibodies 8.5 Leading Regional Markets in the POC Infectious Diseases Testing 8.5.1 Infectious Diseases POC Testing: Regional Markets in 2016 8.6 Infectious Diseases POC Testing Market: Leading Companies 2016 8.7 The POC Infectious Diseases Testing Market Forecast, 2017-2027 8.8 Drivers and Restraints for the POC Infectious Diseases Testing Market, 2017-2027
9. Global POC Pregnancy Testing Market, 2017-2027 9.1 Market Overview, 2016 9.2 Global POC Pregnancy Testing Market, 2016 9.3 The POC Pregnancy Testing Market Forecast 2017-2027 9.3.1 The POC Pregnancy Testing Market: Leading Products 2016 9.3.2 Leading Companies in the POC Pregnancy Testing Market, 2016 9.4 Drivers and Restraints for the POC Pregnancy Testing Market, 2016-2027
10. Global POC Cholesterol Testing Market, 2017-2027 10.1 Market Overview, 2016 10.2 The Global POC Cholesterol Testing Market in 2016 10.3 The POC Cholesterol Testing Market Forecast 2017-2027 10.3.1 POC Cholesterol Testing Biomarkers: Overview 10.3.2 The POC Cholesterol Testing Market by Components 10.3.3 Recent Developments in the POC Cholesterol Testing Market, 2016 10.3.3.1 Roche’s Accutrend Plus 10.3.4 POC Cholesterol Testing Market: Considerations in Production 10.4 Drivers and Restraints for the POC Cholesterol Testing Market, 2016-2027
11. Leading National Markets 2017-2027 11.1 Geographical Breakdown of the World POC Diagnostics Market 11.2 Global POC Diagnostics Market: Regional Forecast 2017-2027 11.3 How Will Regional Market Shares Change to 2027? 11.4 The U.S. POC Diagnostics Market 2017-2027 11.4.1 Healthcare Expending in the US 11.4.2 The US POC Diagnostics Market Dynamics: Drivers and Restraints 11.4.3 The U.S. POC Diagnostics Market Forecast 2017-2027 11.5 The Leading European POC Diagnostics Market 2017-2027 11.5.1 German POC Diagnostics Market Forecast 2017-2027 11.5.2 UK POC Diagnostics Market Forecast 2017-2027 11.5.3 French POC Diagnostics Market Forecast 2017-2027 11.5.4 Spanish POC Diagnostics Market Forecast 2017-2027 11.5.5 Italian POC Diagnostics Market Forecast 2017-2027 11.5.6 The Netherlands POC Diagnostics Market Forecast 2017-2027 11.5.7 Belgian POC Diagnostics Market Forecast 2017-2027 11.5.8 Swiss POC Diagnostics Market Forecast 2017-2027 11.6 The Japanese POC Diagnostics Market 2017-2027 11.6.1 The Japanese POC Diagnostics Market Forecast 2017-2027 11.7 The BRICS Nations POC Diagnostics Market 2017-2027 11.7.1 The Chinese POC Diagnostics Market 2017-2027 11.7.1.1 The Chinese POC Diagnostics Market Forecast 2017-2027 11.7.2 The Indian POC Diagnostics Market 2017-2027 11.7.2.1 The Indian POC Diagnostics Market Forecast 2017-2027 11.7.3 The Brazilian POC Diagnostics Market 2017-2027 11.7.3.1 The Brazilian POC Diagnostics Market Forecast 2017-2027 11.7.4 The Russian POC Diagnostics Market 2017-2027 11.7.4.1 The Russian POC Diagnostics Market Forecast 2017-2027 11.7.5 The South African POC Diagnostics Market 2017-2027 11.7.5.1 The South African POC Diagnostics Market Forecast 2017-2027 11.8 The Rest of the World POC Diagnostics Market 2017-2027 11.8.1 The RoW POC Diagnostics Market Forecast 2017-2027 11.9 Further Insights: Point of Care Diagnostics Approach for Developing Countries
13. POC Diagnostics Market, Qualitative Analysis, 2017-2027 13.1 Introduction 13.2 Drivers and Restraints for the POC Diagnostics Market 13.2.1 Commercial Drivers 13.2.2 Commercial Restraints 13.3 PESTEL Analysis 13.3.1 Political Factors 13.3.2 Economic Factors 13.3.3 Socio-Cultural Factors 13.3.4 Technological Factors 13.3.5 Environmental Factors 13.3.6 Legal Factors 13.4 POC Diagnostics Market: Porters Five Forces Analysis, 2017-2027 13.4.1 Bargaining Power of Supplier 13.4.2 Bargaining Power of Buyer 13.4.3 Competitive Rivalry 13.4.4 Threat of New Entrants 13.4.5 Threat of Substitutes 13.5 POC Diagnostics Market: SWOT Analysis, 2017-2027 13.5.1 Strengths 13.5.1.1 Aids in rapid medical intervention 13.5.2 Weaknesses 13.5.2.1 Awaiting Reimbursement Options 13.5.3 Opportunities 13.5.3.1 Expanding population base 13.5.4 Threats 13.5.4.1 Unmet Needs in Low-Middle Income Countries
14. Conclusions 14.1 The World POC Diagnostics Market in 2016 and 2017 14.2 Current Leading POC Diagnostics Segments 14.3 Leading POC Diagnostics Companies 14.4 Leading Regional Markets 14.5 World POC Diagnostics Market Forecast 2017-2027 14.6 The Future of the POC Diagnostics Market
15. Glossary Visiongain Report Sales Order Form Appendix A About Visiongain Appendix B Visiongain report evaluation form
List of Figures Figure 1.1 Global POC Diagnostics Market Segmentation Overview, 2016 Figure 3.1 Global IVD Market Share (%) by Segment, 2016 Figure 3.2 Global IVD Market Revenues ($bn) for Clinical Diagnostics and POC Diagnostics Segments, 2016 Figure 3.3 Global IVD Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 3.4 The IVD Diagnostics Market Forecast: Revenue ($bn), by Segments, 2016-2027 Figure 3.5 The Clinical Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 3.6 The Global POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 4.1 The POC Diagnostics Market: Shares (%) by Segments, 2016 Figure 4.2 World POC Diagnostics Market Forecast: Revenues ($bn), by Segment, 2016-2027 Figure 4.3 Scope of The POC Diagnostics Market: Revenue ($bn) and CAGR (%), by Segments, 2016 Figure 4.4 Global POC Diagnostics Market Forecast, By Product: Revenue ($bn) and AGR (%), 2016-2027 Figure 4.5 Global POC Diagnostics Market Forecast, By Product: Market Shares (%), 2016 Figure 4.6 Global POC Diagnostics Market Forecast, By Product: Market Shares (%), 2021 Figure 4.7 Global POC Diagnostics Market Forecast, By Product: Market Shares (%), 2027 Figure 5.1 The Global POC Blood Glucose Testing Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 5.2 Market Shares (%) of Fingerstick Testing and CGM Devices in the POC Blood Glucose Monitoring Market, 2016 Figure 5.3 Market Shares (%) of Devices, Test Strips and Other Devices in the POC Blood Glucose Testing Market, 2016 Figure 5.4 Market Shares (%) of Leading National Markets in the POC Blood Glucose Testing Market, 2016 Figure 5.5 POC Blood Glucose Testing Market: Drivers and Restraints 2017-2027 Figure 6.1 The PT/INR POC Testing Market by Point of Use, Market Share (%), 2016 Figure 6.2 The POC Diagnostics Market: Shares (%) by Segments, 2016 Figure 6.3 The Global POC Coagulation Testing Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 6.4 POC Coagulation Testing Market: Drivers and Restraints 2017-2027 Figure 7.1 Global Cardiac Marker Diagnostic Testing Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 7.2 Cardiac Marker Diagnostic Testing Market: Drivers and Restraints, 2017-2027 Figure 8.1 The POC Diagnostics Market: Shares (%) by Segments, 2016 Figure 8.2 Global POC Infectious Diseases Testing Market Forecast: Revenue ($bn), AGR (%), 2016-2027 Figure 8.3 POC Infectious Diseases Testing Market: Drivers and Restraints, 2016-2027 Figure 9.1 Global POC Pregnancy Testing Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 9.2 Global IVD Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 10.1 POC Cholesterol Testing Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 10.2 The POC Cholesterol Testing Market: Drivers and Restraints, 2016-2027 Figure 11.1 Global POC Diagnostics Market, By Region: Revenues ($bn), 2016 Figure 11.2 Global POC Diagnostics Market, By Region: Revenues ($bn), 2017 Figure 11.3 Global POC Diagnostics Market, By Region: Revenue ($bn), 2016-2027 Figure 11.4 Global POC Diagnostics Market, By Region: Market Shares (%), 2016 Figure 11.5 Global POC Diagnostics Market, By Region: Market Shares (%), 2021 Figure 11.6 Global POC Diagnostics Market, By Region: Market Shares (%), 2027 Figure 11.7 US POC Diagnostics Market: Drivers and Restraints, 2016-2027 Figure 11.8 U.S. POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 11.9 European POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 11.10 European POC Diagnostics Market: Market Shares (%) by National Market, 2016 Figure 11.11 European POC Diagnostics Market: Market Shares (%) by National Market, 2021 Figure 11.12 European POC Diagnostics Market: Market Shares (%) by National Market, 2027 Figure 11.13 German POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 11.14 UK POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 11.15 French POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 11.16 Spanish POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 11.17 Italian POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 11.18 The Netherlands POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 11.19 Belgian POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 11.20 Swiss POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 11.21 Japanese POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 11.22 BRICS POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 11.23 The BRICS Nations POC Diagnostics Market Shares (%), by Country, 2016 Figure 11.24 The BRICS Nations POC Diagnostics Market Shares (%), by Country, 2022 Figure 11.25 The BRICS Nations POC Diagnostics Market Shares (%), by Country, 2027 Figure 11.26 Chinese POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 11.27 Indian POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 11.28 Brazilian POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 11.29 Russian POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 11.30 South African POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 11.31 RoW POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 12.1 Roche: Diagnostics Revenue ($bn) and AGR (%), 2016-2027 Figure 12.2 Abbott: POC Diagnostics Revenue ($bn) and AGR (%), 2016-2027 Figure 12.3 Siemens Healthineers: Revenue ($bn) and AGR (%), 2016-2027 Figure 12.4 Alere Inc. Revenue Shares (%), by Business Segment, 2016 Figure 12.5 Alere Professional Diagnostics Segment: Revenue Shares (%), by Group, 2016 Figure 12.6 Alere Inc.: Revenue ($bn) and AGR (%), 2016-2027 Figure 13.1 POC Diagnostics Market: Drivers and Restraints 2017-2027 Figure 13.2 Porter’s Five Forces Analysis of the POC Diagnostics Market, 2017-2027
List of Tables Table 1.1 POC Diagnostics Market Forecast, By Product Revenue ($bn), AGR (%), CAGR (%), 2017-2027 Table 2.1 Types of Genetic In Vitro Diagnostic Tests Currently Available, 2017 Table 2.1 Types of Genetic In Vitro Diagnostic Tests Currently Available, 2017 (continued) Table 2.1 Types of Genetic In Vitro Diagnostic Tests Currently Available, 2017 (continued) Table 2.2 Advantages and Disadvantages of POC Diagnostics, 2017 Table 3.1 The IVD Diagnostics Market: Revenue ($bn) and Market Shares (%) by Segments, 2016 Table 3.2 The IVD Diagnostics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 3.3 The IVD Diagnostics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%) by Segments, 2016-2027 Table 3.4 The Clinical Diagnostics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 3.5 The POC Diagnostics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%),2016-2027 Table 4.1 The IVD Diagnostics Market: Revenue ($bn) and Market Shares (%) by Type of Delivery, 2016 Table 4.2 The POC Diagnostics Market: Revenue ($bn) and Market Shares (%) by Segments, 2016 Table 4.3 Global POC Diagnostics Market Forecast: Revenues ($bn), AGR (%), CAGR (%) by Segment, 2016-2027 Table 5.1 Global Blood Glucose Testing Market, Revenue ($bn) and Share (%), 2016 Table 5.2 POC Blood Glucose Testing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 5.3 Global POC Blood Glucose Testing Devices Market, Revenue ($bn) and Shares (%), by Type of Meter, 2016 Table 5.4 Global POC Blood Glucose Testing Devices Market, Revenue ($bn) and Shares (%), by Components, 2016 Table 5.5 Retail Prices of the Blood Glucose Meters and Strips Currently Available in the Market, by Company (A), 2016 Table 5.6 Retail Prices of the Blood Glucose Meters and Strips Currently Available in the Market, by Company (B-F), 2016 Table 5.7 Retail Prices of the Blood Glucose Meters and Strips Currently Available in the Market, by Company (F-N), 2016 Table 5.8 Retail Prices of the Blood Glucose Meters and Strips Currently Available in the Market, by Company (N-T), 2016 Table 5.9 Retail Prices of the Blood Glucose Meters and Strips Currently Available in the Market, by Company (T-Z), 2016 Table 5.10 Leading National Markets for the POC Blood Glucose Testing Market, Revenue ($bn) and Shares (%),2016 Table 5.11 Diabetes Care Business Segment, Revenue ($bn) and Shares (%), by Leading Companies, 2016 Table 5.12 List of Some Other Companies in the POC Blood Glucose Testing Market, 2016 Table 5.13 Advantages and Disadvantages of the Currently Available CGM, by Product, 2016 Table 5.13 Advantages and Disadvantages of the Currently Available CGM, by Product, 2016 (continued) Table 6.1 Global Rapid Coagulation Testing Market, Revenue ($bn) and Share (%), 2016 Table 6.2 List of Some Products in the POC Coagulation Testing Market for Self Testing and Professional Testing, 2016 Table 6.3 The PT/INR POC Testing Market, Revenue ($bn) and Shares (%), by Point of Use, 2016 Table 6.4 The Price of Some PT/INR POC Testing Systems ($), 2016 Table 6.5 The PT/INR POC Testing Market, Revenue ($m) and Shares (%), by Components, 2016 Table 6.6 POC Rapid Coagulation Testing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 7.1 Global Cardiac Marker Diagnostic Testing Market, Revenue ($bn) and Share (%), 2016 Table 7.2 Time to Elevation for Some Cardiac Markers, 2016 Table 7.3 Clinical Use of the Cardiac Biomarkers, 2017 Table 7.4 POC Rapid Cardiac Marker Testing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 7.5 Leading Products in the Cardiac Marker Diagnostic Testing Market, by Company, 2016 Table 8.1 Global POC Infectious Diseases Testing Market, Revenue ($bn) and Share (%), 2016 Table 8.2 Global POC Infectious Diseases Testing Market, Revenue ($bn) and Share (%), 2016 Table 8.3 Strengths and Limitations of Some Leading Products in the HIV Rapid Testing Market, 2016 Table 8.4 Currently Approved HIV Diagnostic Kits Through Premarket Applications (PMAs), by Date of FDA Approval, 2017 Table 8.4 Currently Approved HIV Diagnostic Kits Through Premarket Applications (PMAs), by Date of FDA Approval, 2017 (continued) Table 8.5 HIV RDTs For Self-Testing In The Pipeline, 2017 Table 8.6 List of Some Products in the POC Hepatitis Testing Market, 2016 Table 8.7 List of Some Products in the Rapid Influenza Testing Market, 2016 Table 8.8 POC Infectious Diseases Testing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 9.1 Global POC Pregnancy Testing Market, Revenue ($bn) and Share (%), 2016 Table 9.2 POC Pregnancy Testing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 10.1 Global POC Cholesterol Testing Market, Revenue ($bn) and Share (%), 2016 Table 10.2 POC Cholesterol Testing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 11.1 Global POC Diagnostics Market, By Region: Revenues ($bn) and Market Share (%) 2016 and 2017 Table 11.2 Global POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 11.3 U.S. POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 11.4 European POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 11.4 European POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027 (continued) Table 11.5 German POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 11.6 UK POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 11.7 French POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 11.8 Spanish POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 11.9 Italian POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 11.10 The Netherlands POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 11.11 Belgian POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 11.12 Swiss POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 11.13 Japanese POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 11.14 BRICS POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 11.15 China POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 11.16 Indian POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 11.17 Brazilian POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 11.18 Russian POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 11.19 South African POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 11.20 RoW POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 12.1 F. Hoffmann-La Roche AG: Overview, 2017 Table 12.2 Roche Diagnostics: Key Product Launches Planned for 2017 Table 12.3 Roche Diagnostics: Revenue ($m) and Revenue Share (%), by Business Area, 2016 Table 12.4 Roche Diagnostics Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 12.5 Abbott: Overview, 2017 Table 12.6 Abbott Diagnostics: Business Highlights, 2016 Table 12.7 Abbott Diagnostics Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 12.8 Siemens Healthineers: Overview, 2017 Table 12.9 Siemens Healthineers POC Diagnostics Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 12.10 Alere Inc.: Overview, 2017 Table 12.11 Alere Inc.: Product Portfolio (Cardiometabolic), 2017 Table 12.12 Alere Inc.: Product Portfolio (Cardiometabolic, Infectious Diseases), 2017 Table 12.13 Alere Inc.: Product Portfolio (Infectious Diseases), 2017 Table 12.14 Alere Inc.: Product Portfolio (Infectious Diseases cont.) 2017 Table 12.15 Alere Inc.: Product Portfolio (Toxicology), 2017 Table 12.16 Alere Inc.: Revenue ($bn) and Change (%), by Business Area, 2015 & 2016 Table 12.17 Alere Inc. Revenue ($bn), AGR (%), CAGR (%), 2016-2027 Table 13.1 POC Diagnostics Market: SWOT Analysis, 2017-2027
3M Abaxis Abaxis Inc Abbott Cardiovascular Inc Abbott Diabetes Care Abbott Molecular Inc. Abbott Point of Care Abbott S.r.l. Abbott SA Advanced Care Affymetrix, Inc. AgaMatrix Agendia BV Alere Health Systems Inc. Alere Medical Japan Amgenix International Inc Arkay Ascensia Diabetes Care Astra Zeneca AutoGenomics, Inc. Avioq, Inc. B Braun Bayer BBI Helathcare Becton Dickinson Beijing Wantai Biological Pharmacy Enterprise Co., Ltd Biofire Diagnostics BioLytical Laboratories Bionime Bio-Rad Laboratories Biosense Medical BioSign Biosite Diagnostics Biosynex Medtech Boehringer Ingelheim Calypte Biomedical Celera Diagnostics Cepheid Cerus Corporation Chembio Diagnostic Systems Cholestech Church & Dwight Clinical Micro Sensors, Inc. Concateno Core Diagnostics CVS/Pharmacy Dako Denmark A/S DakoCytomation Denmark A/S Dario Health Decision Diagnostics Corp. Dexcom Diabetic Supply of Suncoast Diagnostic Devices DiME Early Pregnancy Tests.com EKF Diagnostics Entra Helath Systems Exact Sciences Corporation EY Laboratories Fenwal Inc Fifty50 Medical Focus Diagnostics ForaCare Fujirebio Genentech General Life Biotechnology Ltd Genesis Health Technology GenMark Diagnostics Gen-Probe, Inc. Genzyme Gluco Com Grove Instruments Halifax Helena Laboratories Hema technologies Hologic, Inc. Home Access Health Corporation Horiba IHelath Labs Illumina, Inc. IME-DC IND Diagnostic Inc. Infopia Insight Pharmaceuticals Instrumentation Laboratory (a company of Werfen Group) InTec Products Integrity Applications Ltd. International Technidyne Corporation Inverness Medical Iris Molecular Diagnostics JANT Pharmacal Corporation Johnson & Johnson LifeScan Livongo Health Luminex Molecular Diagnostics, Inc. Marnes La Coquette Maxim Biomedical Inc Medford Medix Biochemica Medor Menarini Meridian Bioscience Mitsubishi Chemical MIZUHO MEDY Company Myriad Genetic Laboratories, Inc. Nani Daman Nanosphere, Inc. Nanostring Technologies Nipro Diadnostics Nova Diabetes Oak Tree Health Oak Tree International Holdings Omnis Health One Drop OraSure Technologies Orgenics OrSense NBM-200G Ortho-Clinical Diagnostics, Inc. Osmetech Molecular Diagnostics ParagonDx, LLC Partec Pathwork Diagnostics Inc. Pharma Tech Solutions Philosys POC Medical System PointCare Technologies Polymer Technology Systems Inc Premier Medical Corporation Princeton Biomedtech Procter & Gamble Prodigy Diabetes Care Proteome Systems Quest Diagnostics Quidel Remel/Thermofisher Response Biomedical Corporation Roche Diagnostics Corporation Roche Molecular Systems, Inc. RunBio Biotech Company SA Scientific Sanofi Savyon Diagnostics Sedia Biosciences Corporation, USA Sekisui Medical Company Shanghai Kehua Bioengineering Co., Ltd. Siemens Financial Services GmbH Siemens Healthcare Diagnostics GmbH Siemens Healthcare Diagnostics SA Siemens Healthcare EOOD Siemens Healthineers Spartan Bioscience, Inc. Spirit Healthcare Standard Diagnostics Inc. Swiss Precision Diagnostics Symphony Sysmex Target Telcare Thermo Fisher Scientific Third Wave Technologies Inc. Tm Bioscience Corporation TrimGen Corporation Trinity Biotech Trividia Health Trovagene U.S. Diagnostics Unimed International Universal Biosensors Universal Diagnostics Ventana Medical Systems, Inc. Veridex, LLC. Vysis Walgreens Walmart WellDoc Corporation xDx Inc. YD Diagnostics Ypsomed
List of Organizations American Diabetes Association Anti Coagulation Self-Monitoring Alliance Atrial Fibrillation Association Bill & Melinda Gates Foundation Cancer Research UK Children’s Heart Federation College of American Pathologists Diabetes Research Unit Cymru European Diagnostics Manufacturers Association European Heart Network Federal Joint Committee - Gemeinsamer Bundesausschuss Food Drug and Administration German Federal Ministry of Health International Diabetes Federation Internet Stroke Center King's College London MATCH Group Mechanical Heart Valve Support Group Ministry of Health, Labor and Welfare National Health and Medical Research Council National Health Services Swansea University, UK The National Institute for Health and Clinical Excellence The PATH’s Diagnostics Group U.S. Centers for Medicare & Medicaid Services UNITAID Universidad Peruana Cayetano Heredia University of California US Preventative Services Task Force World Health Organization
Download sample pages
Complete the form below to download your free sample pages for POC Diagnostics Market Forecast 2017-2027
The Alzheimer’s Disease Therapeutics and Diagnostics Market will reach $7.93bn in 2018. The Alzheimer’s Disease Therapeutics and Diagnostics Market is...
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
